Anders W. Mølby Nielsen

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

Mette Thune Mouritzen, Andreas Carus, Morten Ladekarl et al. · Cancers · 2021 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Twin Studies and Other Genetical Investigations in the Danish Cancer Registry

Th. Busk, J Clemmesen, Anders W. Mølby Nielsen · British Journal of Cancer · 1948 · 37 citations · Full text

Life Sciences, Genetics, Oncology +13

Severe steroid refractory gastritis induced by Nivolumab: A case report

Helene Hjorth Vindum, Jørgen Agnholt, Anders W. Mølby Nielsen et al. · World Journal of Gastroenterology · 2020 · 26 citations · Full text

Medicine, Immunology, Oncology +15

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Mette Thune Mouritzen, Karen F. Junker, Andreas Carus et al. · Acta Oncologica · 2022 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study

Anders W. Mølby Nielsen, Lise Bech Jellesmark Thorsen, Demet Özcan et al. · The Lancet Regional Health - Europe · 2024 · 17 citations · Full text

Medicine, Oncology, Radiation Oncology +16